Atlas Trials

A Clinical Trial of an Quadrivalent Influenza Virus Subunit Vaccine in Chinese Children Aged 6 to 35 Months

Clinical trial NCT05645900 · COMPLETED

Trial details

NCT number
NCT05645900
Sponsor
Ab&B Bio-tech Co., Ltd.JS
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Influenza
Start date
2023-02-06
Primary completion
2023-10-13
Enrollment
2772

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.